Bosh sahifaSCNI • NASDAQ
add
Scinai Immunotherapeutics Ltd - ADR
Yopilish kursi
3,53 $
Kunlik diapazon
3,46 $ - 3,58 $
Yillik diapazon
2,34 $ - 8,92 $
Bozor kapitalizatsiyasi
3,05 mln USD
Oʻrtacha hajm
10,23 ming
Bozor yangiliklari
MarketWatch
42 daqiqa oldin
U.S. stocks are falling. Here’s why Goldman says to stay invested in 2025.
0,67%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 168,00 ming | — |
Joriy xarajat | 2,17 mln | 3,28% |
Sof foyda | 10,46 mln | 236,50% |
Sof foyda marjasi | 6,22 ming | — |
Har bir ulushga tushum | — | — |
EBITDA | -1,92 mln | 1,79% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,03 mln | -83,78% |
Jami aktivlari | 12,26 mln | -34,02% |
Jami passivlari | 2,26 mln | -89,39% |
Umumiy kapital | 10,00 mln | — |
Tarqatilgan aksiyalar | 853,00 ming | — |
Narxi/balansdagi bahosi | 0,30 | — |
Aktivlardan daromad | -44,63% | — |
Kapitaldan daromad | -48,85% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 10,46 mln | 236,50% |
Operatsiyalardan naqd pul | -2,04 mln | 8,28% |
Sarmoyadan naqd pul | -4,00 ming | 80,00% |
Moliyadan naqd pul | 8,00 ming | -99,26% |
Naqd pulning sof oʻzgarishi | -1,92 mln | -67,45% |
Boʻsh pul | -2,48 mln | -53,77% |
Haqida
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
Tashkil etilgan
1-yan, 2003
Sayt
Xodimlar soni
31
